Free shipping from 69,00 € and always free returns

Diosven 300 mg - trattamento insuffucienza venosa e fragilità capillare 20 compresse

(0)
Productor: C.t. laboratorio farmaceutico s.r.l.
info prodotto Richiedi info sul prodotto
Product not active click on Notify me to know when it will be available again
info resi e spedizione

Information on returns and shipments

info pagamenti

Payment methods

Authorized company for online trading of
Medicines authorized by the Ministry of Health
99& satisfied customers
Product Description

C.T.

Tablets

Composition:

1 tablet contains: Active ingredient: Diosmin 300 mg For excipients see 6.1

Excipients

Maize starch, lactose, polyvinylpyrrolidone, talc, magnesium stearate.

Therapeutic indications

Symptoms attributable to venous insufficiency; states of capillary fragility.

Contraindications

Hypersensitivity to the active ingredient or to any of the excipients.

Dosage

On average 1 tablet 3 times a day, unless otherwise prescribed by your doctor.

Warnings and precautions

None.

Interactions

The product can be administered without risk in conjunction with other drugs, including anticoagulants.

Side effects

The use of DIOSVEN at the recommended doses in therapy rarely gives rise to side effects. However, rare cases of gastralgia, nausea, diarrhea, dizziness have been reported, always mild and not requiring interruption of treatment.

Pregnancy and breastfeeding

The safety of the drug during pregnancy has not been established, therefore it is advisable not to administer the product during pregnancy.

Format

20 tablets

Product Code:FRCM046560

Price Trend

This product has been on sale since 25/09/2017

In the last 30 days, the product's lowest price was 9,77 €

5% EXTRA DISCOUNT on FIRST ORDER! Register and discover the WELCOME Coupon!
To enhance your website experience, Farmacosmo.com uses different types of cookies. You can click OK, to allow them, or manage them individually. By clicking on the ''x'' you don't accept any cookies and other tracking methods other than technical ones. To read more see our Cookie Policy. Cookie Policy